JF
ASMB icon

Jump Financial’s Assembly Biosciences ASMB Stock Holding History

Jump Financial’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Buy
+10,917
New +$311K ﹤0.01% 1475
2022
Q1 		– Sell
-1,692
Closed -$47K – 1534
2021
Q4 		$47K Buy
+1,692
New +$55.5K ﹤0.01% 1313
2021
Q1 		– Sell
-3,008
Closed -$218K – 927
2020
Q4 		$218K Buy
+3,008
New +$353K 0.04% 739

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Jump Financial's ASMB Position: Q1 2026 in Review

Jump Financial opened a new position in Assembly Biosciences (ASMB) in Q1 2026: 10,917 shares worth $303K. The stake represents ﹤0.01% of the portfolio and ranks #1475 among its holdings. This is a return to the name: Jump Financial previously reported a position in ASMB as recently as Q4 2021.

Jump Financial first reported a position in ASMB in Q4 2020 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Jump Financial held 10,917 shares of Assembly Biosciences worth $303K as of Q1 2026.
  • Assembly Biosciences was a new Jump Financial position in Q1 2026.
  • Assembly Biosciences made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1475 holding.
  • Jump Financial first reported a position in Assembly Biosciences in Q4 2020 and has held it in 3 quarters since.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.